Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.

about

A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis.

P2860

Q55025912-70B525C2-9C54-45BF-8F32-94C2332505B6

P2860

Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.

Item

http://www.wikidata.org/entity/Q51058654

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@en

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@nl

type

Item

label

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@en

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@nl

prefLabel

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@en

Evaluation of 5-fluorouracil d ...... llowing adjuvant Capecitabine.

@nl

P1476

Evaluation of 5-fluorouracil d ...... ollowing adjuvant Capecitabine

@en

P2093

Adriana Romiti

http://www.w3.org/2001/XMLSchema#string

Concetta Elisa Onesti

http://www.w3.org/2001/XMLSchema#string

Elisabetta Anselmi

http://www.w3.org/2001/XMLSchema#string

Federica Mazzuca

http://www.w3.org/2001/XMLSchema#string

Francesca Romana Di Pietro

http://www.w3.org/2001/XMLSchema#string

Luana Lionetto

http://www.w3.org/2001/XMLSchema#string

Maria Bassanelli

http://www.w3.org/2001/XMLSchema#string

Maurizio Simmaco

http://www.w3.org/2001/XMLSchema#string

Michela Roberto

http://www.w3.org/2001/XMLSchema#string

Rosa Falcone

http://www.w3.org/2001/XMLSchema#string

P2860

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.

Capecitabine: a review.

Candidate mechanisms for capecitabine-related hand-foot syndrome.

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity

P2888

s00228-016-2160-8

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-016-2160-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27864592

http://www.w3.org/2001/XMLSchema#string

Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.

about

P2860

P2860

Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698